FR2940289B1 - Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas - Google Patents
Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreasInfo
- Publication number
- FR2940289B1 FR2940289B1 FR0807426A FR0807426A FR2940289B1 FR 2940289 B1 FR2940289 B1 FR 2940289B1 FR 0807426 A FR0807426 A FR 0807426A FR 0807426 A FR0807426 A FR 0807426A FR 2940289 B1 FR2940289 B1 FR 2940289B1
- Authority
- FR
- France
- Prior art keywords
- amino
- treatment
- pancreatic cancer
- hydroxyquinoline class
- class derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0807426A FR2940289B1 (fr) | 2008-12-23 | 2008-12-23 | Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas |
CA2748124A CA2748124A1 (fr) | 2008-12-23 | 2009-12-23 | Compositions agonistes de ppar et procedes d'utilisation |
AU2009332511A AU2009332511A1 (en) | 2008-12-23 | 2009-12-23 | PPAR agonist compositions and methods of use |
US13/140,514 US20110251238A1 (en) | 2008-12-23 | 2009-12-23 | Ppar agonist compositions and methods of use |
EP09805949A EP2382193A1 (fr) | 2008-12-23 | 2009-12-23 | Compositions agonistes de ppar et procédés d'utilisation |
PCT/IB2009/055950 WO2010073235A1 (fr) | 2008-12-23 | 2009-12-23 | Compositions agonistes de ppar et procédés d'utilisation |
CN2009801519893A CN102300847A (zh) | 2008-12-23 | 2009-12-23 | Ppar激动剂组合物及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0807426A FR2940289B1 (fr) | 2008-12-23 | 2008-12-23 | Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2940289A1 FR2940289A1 (fr) | 2010-06-25 |
FR2940289B1 true FR2940289B1 (fr) | 2014-09-12 |
Family
ID=40785273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0807426A Expired - Fee Related FR2940289B1 (fr) | 2008-12-23 | 2008-12-23 | Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110251238A1 (fr) |
EP (1) | EP2382193A1 (fr) |
CN (1) | CN102300847A (fr) |
AU (1) | AU2009332511A1 (fr) |
CA (1) | CA2748124A1 (fr) |
FR (1) | FR2940289B1 (fr) |
WO (1) | WO2010073235A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201208775D0 (en) | 2012-05-18 | 2012-07-04 | Uni I Oslo | Chemical compounds |
CN104903494B (zh) * | 2012-09-21 | 2017-11-03 | 瑞奥可塞恩探索集团有限公司 | 用于电解液体的电池 |
GB201320506D0 (en) | 2013-11-26 | 2014-01-01 | Uni I Oslo | Cyclic amino compounds for the use in the treatment of cardiac disorders |
WO2018059437A1 (fr) * | 2016-09-27 | 2018-04-05 | Beigene, Ltd. | Traitement de cancers à l'aide d'une combinaison comprenant des inhibiteurs de parp |
CN109843857B (zh) | 2016-10-05 | 2023-01-06 | 米托布里奇公司 | Ppar激动剂化合物的结晶和盐形式 |
CN106822901A (zh) * | 2016-11-01 | 2017-06-13 | 中山大学 | 过氧化物酶体增殖剂激活受体α对肉毒碱棕榈酰基转移酶1C的直接调控作用及抗肿瘤应用 |
CN110164511A (zh) * | 2019-05-08 | 2019-08-23 | 重庆科技学院 | 一种快速筛选PPARα/δ双重激动剂的方法 |
WO2024040132A2 (fr) * | 2022-08-16 | 2024-02-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Interactions synergiques pour traitement anticancéreux amélioré |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
EP1565185A4 (fr) * | 2002-11-07 | 2011-01-05 | Technion Res & Dev Foundation | Chelateurs du fer et compositions pharmaceutiques les renfermant |
RS50670B (sr) * | 2004-05-21 | 2010-06-30 | Novartis Vaccines And Diagnostics Inc. | Supstitucionisani derivati hinolina kao mitotički kinezinski inhibitori |
WO2007146824A2 (fr) * | 2006-06-08 | 2007-12-21 | Array Biopharma Inc. | Quinolines et méthodes d'utilisation |
FR2913976B1 (fr) * | 2007-03-23 | 2013-04-26 | Biopharmed | Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers. |
WO2009140215A2 (fr) * | 2008-05-11 | 2009-11-19 | Geraghty, Erin | Procédé pour traiter des infections bactériennes résistant au médicament et d'autres infections par du clioquinol, de la phanquinone et des composés apparentés |
-
2008
- 2008-12-23 FR FR0807426A patent/FR2940289B1/fr not_active Expired - Fee Related
-
2009
- 2009-12-23 CN CN2009801519893A patent/CN102300847A/zh active Pending
- 2009-12-23 WO PCT/IB2009/055950 patent/WO2010073235A1/fr active Application Filing
- 2009-12-23 AU AU2009332511A patent/AU2009332511A1/en not_active Abandoned
- 2009-12-23 CA CA2748124A patent/CA2748124A1/fr not_active Abandoned
- 2009-12-23 EP EP09805949A patent/EP2382193A1/fr not_active Withdrawn
- 2009-12-23 US US13/140,514 patent/US20110251238A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110251238A1 (en) | 2011-10-13 |
FR2940289A1 (fr) | 2010-06-25 |
EP2382193A1 (fr) | 2011-11-02 |
WO2010073235A1 (fr) | 2010-07-01 |
AU2009332511A1 (en) | 2011-07-14 |
CN102300847A (zh) | 2011-12-28 |
CA2748124A1 (fr) | 2010-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2940289B1 (fr) | Derives de la classe des hydroxyquinoleines aminees pour le traitement du cancer du pancreas | |
ATE453635T1 (de) | C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
FR2925339B1 (fr) | Medicament pour le traitement du cancer du pancreas | |
HK1138850A1 (en) | Quinoline derivatives for the treatment of inflammatory diseases | |
ZA201006868B (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
EP2063897A4 (fr) | Inhibiteurs de kinases utiles pour le traitement de maladies prolifératives | |
EP2063896A4 (fr) | Inhibiteurs de la kinase utiles dans le traitement de maladies prolifératives | |
FR2932478B1 (fr) | Composes utiles pour le traitement des cancers. | |
DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
IL196470A (en) | Antagonist antibody for cancer treatment | |
ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
HK1130208A1 (en) | Alpha-msh derivatives for the treatment of photodermatoses -msh | |
EA201000895A1 (ru) | Композиции и способы для лечения лизосомных болезней | |
DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
NO20091266L (no) | Fremgangsmåter for administrering av langvarige hypoglykemiske midler | |
ATE502944T1 (de) | 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs | |
DE602006010449D1 (de) | Behandlung von geflügel zwecks reduzierung der futon ascites | |
BRPI0822129A2 (pt) | Inibidores de aldh-2c no tratamento de vício. | |
DK2099446T3 (da) | Fremgangsmåde til behandling af inflammatorisk tarmsygdom | |
BR112012003653A2 (pt) | "método de tratar o câncer." | |
FR2913976B1 (fr) | Derives de la classe des hydroxyquinoleines aminees pour le traitement de cancers. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20150831 |